drugset / Trial / NCT00257556

A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa

NCT00257556

Phase 4 Completed 80 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

Prospective open label, randomised, parallel group, comparative pilot.

Timeline

Start
2005-10
Primary completion
2008-07
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gonal-f Protein / enzyme biologic 150 iu Subcutaneous
Subject Menopur Protein / enzyme biologic 150 iu Subcutaneous

Indications